Wei Yao - Publications

Affiliations: 
Tulane University, New Orleans, LA, United States 

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Jordan JH, Cheng HN, Easson MW, Yao W, Condon BD, Gibb BC. Effect of Nanocellulose on the Properties of Cottonseed Protein Isolate as a Paper Strength Agent. Materials (Basel, Switzerland). 14. PMID 34361323 DOI: 10.3390/ma14154128  0.686
2021 Yao W, Wang K, Ismaiel YA, Wang R, Cai X, Teeler M, Gibb BC. Electrostatic Potential Field Effects on Amine Macrocyclizations within Yoctoliter Spaces: Supramolecular Electron Withdrawing/Donating Groups. The Journal of Physical Chemistry. B. PMID 34355901 DOI: 10.1021/acs.jpcb.1c05238  0.679
2020 Yao W, Wang K, Wu A, Reed WF, Gibb BC. Anion binding to ubiquitin and its relevance to the Hofmeister effects. Chemical Science. 12: 320-330. PMID 34163600 DOI: 10.1039/d0sc04245e  0.32
2020 Jiang M, Liu R, Liu L, Kot A, Liu X, Xiao W, Jia J, Li Y, Lam KS, Yao W. Identification of osteogenic progenitor cell-targeted peptides that augment bone formation. Nature Communications. 11: 4278. PMID 32855388 DOI: 10.1038/S41467-020-17417-9  0.319
2019 Sullivan MR, Yao W, Gibb BC. The thermodynamics of guest complexation to octa-acid and tetra--methyl octa-acid: reference data for the sixth statistical assessment of modeling of proteins and ligands (SAMPL6). Supramolecular Chemistry. 31: 184-189. PMID 31555042 DOI: 10.1080/10610278.2018.1549327  0.541
2019 Pathak P, Yao W, Hook KD, Vik R, Winnerdy FR, Brown JQ, Gibb BC, Pursell Z, Phan AT, Jayawickramarajah J. Bright G-Quadruplex Nanostructures Functionalized with Porphyrin Lanterns. Journal of the American Chemical Society. PMID 31322869 DOI: 10.1021/Jacs.9B03250  0.373
2019 Wang K, Cai X, Yao W, Tang D, Kataria R, Ashbaugh HS, Byers LD, Gibb BC. Electrostatic control of macrocyclization reactions within nano-spaces. Journal of the American Chemical Society. PMID 30929421 DOI: 10.1021/Jacs.9B02287  0.717
2018 Rizzi A, Murkli S, McNeill JN, Yao W, Sullivan M, Gilson MK, Chiu MW, Isaacs L, Gibb BC, Mobley DL, Chodera JD. Overview of the SAMPL6 host-guest binding affinity prediction challenge. Journal of Computer-Aided Molecular Design. PMID 30415285 DOI: 10.1007/S10822-018-0170-6  0.547
2018 Awan B, Turkov D, Schumacher C, Jacobo A, McEnerney A, Ramsey A, Xu G, Park D, Kalomoiris S, Yao W, Jao LE, Allende ML, Lebrilla CB, Fierro FA. FGF2 Induces Migration of Human Bone Marrow Stromal Cells by Increasing Core Fucosylations on N-Glycans of Integrins. Stem Cell Reports. PMID 29983388 DOI: 10.1016/J.Stemcr.2018.06.007  0.304
2018 Stern AR, Yao X, Wang Y, Berhe A, Dallas M, Johnson ML, Yao W, Kimmel DB, Lane NE. Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats. Bone Reports. 8: 115-124. PMID 29955630 DOI: 10.1016/J.Bonr.2018.02.005  0.321
2018 Sullivan MR, Yao W, Tang D, Ashbaugh HS, Gibb BC. The Thermodynamics of Anion Complexation to Nonpolar Pockets. The Journal of Physical Chemistry. B. PMID 29373793 DOI: 10.1021/Acs.Jpcb.7B12259  0.537
2017 Kot A, Zhong ZA, Zhang HL, Lay YE, Lane NE, Yao W. Sexually dimorphic regulation of osteoprogenitor progesterone in bone stromal cells. Journal of Molecular Endocrinology. PMID 28871061 DOI: 10.1530/Jme-17-0076  0.325
2017 Zhong ZA, Kot A, Lay YE, Zhang H, Jia J, Lane NE, Yao W. Sex-Dependent, Osteoblast Stage-Specific Effects of Progesterone Receptor on Bone Acquisition. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 28569405 DOI: 10.1002/Jbmr.3186  0.32
2017 Murray J, Kim K, Ogoshi T, Yao W, Gibb BC. The aqueous supramolecular chemistry of cucurbit[n]urils, pillar[n]arenes and deep-cavity cavitands. Chemical Society Reviews. PMID 28338130 DOI: 10.1039/C7Cs00095B  0.38
2016 Mohan G, Lay EY, Berka H, Ringwood L, Kot A, Chen H, Yao W, Lane NE. A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis. Calcified Tissue International. PMID 27679514 DOI: 10.1007/S00223-016-0195-6  0.304
2015 Zhong ZA, Sun W, Chen H, Zhang H, Lane NE, Yao W. Inactivation of the Progesterone Receptor in Mx1+ Cells Potentiates Osteogenesis in Calvaria but Not in Long Bone. Plos One. 10: e0139490. PMID 26431032 DOI: 10.1371/Journal.Pone.0139490  0.328
2015 Yao W, Dai W, Jiang L, Lay EY, Zhong Z, Ritchie RO, Li X, Ke H, Lane NE. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 26384674 DOI: 10.1007/S00198-015-3308-6  0.313
2015 Zhong ZA, Sun W, Chen H, Zhang H, Lay YE, Lane NE, Yao W. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice. Bone. 81: 614-619. PMID 26232373 DOI: 10.1016/J.Bone.2015.07.034  0.317
2015 Dai W, Jiang L, Lay YA, Chen H, Jin G, Zhang H, Kot A, Ritchie RO, Lane NE, Yao W. Prevention of glucocorticoid induced bone changes with beta-ecdysone. Bone. 74: 48-57. PMID 25585248 DOI: 10.1016/J.Bone.2015.01.001  0.328
2015 Yao W, Lane NE. Targeted delivery of mesenchymal stem cells to the bone. Bone. 70: 62-5. PMID 25173607 DOI: 10.1016/J.Bone.2014.07.026  0.316
2014 Lee TC, Burghardt AJ, Yao W, Lane NE, Majumdar S, Gullberg GT, Seo Y. Improved trabecular bone structure of 20-month-old male spontaneously hypertensive rats. Calcified Tissue International. 95: 282-91. PMID 25106873 DOI: 10.1007/S00223-014-9893-0  0.301
2014 Amugongo SK, Yao W, Jia J, Dai W, Lay YA, Jiang L, Harvey D, Zimmermann EA, Schaible E, Dave N, Ritchie RO, Kimmel DB, Lane NE. Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats. Bone. 67: 257-68. PMID 25016965 DOI: 10.1016/J.Bone.2014.04.033  0.309
2014 Amugongo SK, Yao W, Jia J, Lay YAE, Dai W, Jiang L, Walsh D, Li CS, Dave NKN, Olivera D, Panganiban B, Ritchie RO, Lane NE. Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass Osteoporosis International. 25: 1735-1750. PMID 24722767 DOI: 10.1007/S00198-014-2678-5  0.322
2013 Yao W, Guan M, Jia J, Dai W, Lay YA, Amugongo S, Liu R, Olivos D, Saunders M, Lam KS, Nolta J, Olvera D, Ritchie RO, Lane NE. Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells (Dayton, Ohio). 31: 2003-14. PMID 23818248 DOI: 10.1002/Stem.1461  0.312
2013 Jia J, Yao W, Amugongo S, Shahnazari M, Dai W, Lay YA, Olvera D, Zimmermann EA, Ritchie RO, Li CS, Alliston T, Lane NE. Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model. Bone. 52: 424-32. PMID 23088940 DOI: 10.1016/J.Bone.2012.10.017  0.3
2012 Collette NM, Genetos DC, Economides AN, Xie L, Shahnazari M, Yao W, Lane NE, Harland RM, Loots GG. Targeted deletion of Sost distal enhancer increases bone formation and bone mass. Proceedings of the National Academy of Sciences of the United States of America. 109: 14092-7. PMID 22886088 DOI: 10.1073/Pnas.1207188109  0.321
2012 Zhong Z, Zylstra-Diegel CR, Schumacher CA, Baker JJ, Carpenter AC, Rao S, Yao W, Guan M, Helms JA, Lane NE, Lang RA, Williams BO. Wntless functions in mature osteoblasts to regulate bone mass. Proceedings of the National Academy of Sciences of the United States of America. 109: E2197-204. PMID 22745162 DOI: 10.1073/Pnas.1120407109  0.33
2012 Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nature Medicine. 18: 456-62. PMID 22306732 DOI: 10.1038/Nm.2665  0.312
2011 Shahnazari M, Yao W, Wang B, Panganiban B, Ritchie RO, Hagar Y, Lane NE. Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 569-81. PMID 20839286 DOI: 10.1002/Jbmr.249  0.328
2010 Yao W, Dai W, Shahnazari M, Pham A, Chen Z, Chen H, Guan M, Lane NE. Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice. Plos One. 5: e11410. PMID 20625385 DOI: 10.1371/Journal.Pone.0011410  0.32
2010 Lane NE, Yao W. Glucocorticoid‐induced bone fragility Annals of the New York Academy of Sciences. 1192: 81-83. PMID 20392221 DOI: 10.1111/J.1749-6632.2009.05228.X  0.321
2010 Shahnazari M, Yao W, Dai W, Wang B, Ionova-Martin SS, Ritchie RO, Heeren D, Burghardt AJ, Nicolella DP, Kimiecik MG, Lane NE. Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats. Bone. 46: 1267-74. PMID 19931661 DOI: 10.1016/J.Bone.2009.11.019  0.326
2010 Yao W, Cheng Z, Shahnazari M, Dai W, Johnson ML, Lane NE. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 25: 190-9. PMID 19594295 DOI: 10.1359/Jbmr.090719  0.325
2009 Lane NE, Yao W. Developments in the scientific understanding of osteoporosis Arthritis Research & Therapy. 11: 228-228. PMID 19497136 DOI: 10.1186/Ar2656  0.303
2009 Henley C, Davis J, Miller G, Shatzen E, Cattley R, Li X, Martin D, Yao W, Lane N, Shalhoub V. The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. European Journal of Pharmacology. 616: 306-13. PMID 19470383 DOI: 10.1016/J.Ejphar.2009.05.013  0.326
2009 Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 24: 209-20. PMID 18847326 DOI: 10.1359/Jbmr.81005  0.324
2008 Shahnazari M, Yao W, Corr M, Lane NE. Targeting the Wnt signaling pathway to augment bone formation. Current Osteoporosis Reports. 6: 142-8. PMID 19032924 DOI: 10.1007/S11914-008-0025-5  0.306
2008 Yao W, Cheng Z, Pham A, Busse C, Zimmermann EA, Ritchie RO, Lane NE. Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis and Rheumatism. 58: 3485-97. PMID 18975341 DOI: 10.1002/Art.23954  0.331
2008 Ritchie RO, Koester KJ, Ionova S, Yao W, Lane NE, Ager JW. Measurement of the toughness of bone: a tutorial with special reference to small animal studies. Bone. 43: 798-812. PMID 18647665 DOI: 10.1016/J.Bone.2008.04.027  0.318
2008 Yao W, Cheng Z, Busse C, Pham A, Nakamura MC, Lane NE. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis and Rheumatism. 58: 1674-86. PMID 18512788 DOI: 10.1002/Art.23454  0.311
2008 You L, Temiyasathit S, Lee P, Kim CH, Tummala P, Yao W, Kingery W, Malone AM, Kwon RY, Jacobs CR. Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. Bone. 42: 172-9. PMID 17997378 DOI: 10.1016/J.Bone.2007.09.047  0.328
2007 Balooch G, Yao W, Ager JW, Balooch M, Nalla RK, Porter AE, Ritchie RO, Lane NE. The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids. Arthritis and Rheumatism. 56: 3726-37. PMID 17968931 DOI: 10.1002/Art.22976  0.33
2007 Yao W, Cheng Z, Koester KJ, Ager JW, Balooch M, Pham A, Chefo S, Busse C, Ritchie RO, Lane NE. The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength. Bone. 41: 804-12. PMID 17825637 DOI: 10.1016/J.Bone.2007.06.021  0.323
2007 Yao W, Su M, Zhang Q, Tian X, Setterberg RB, Blanton C, Lundy MW, Phipps R, Jee WS. Risedronate did not block the maximal anabolic effect of PTH in aged rats. Bone. 41: 813-9. PMID 17716965 DOI: 10.1016/J.Bone.2007.07.005  0.33
2007 Wu Y, Torchia J, Yao W, Lane NE, Lanier LL, Nakamura MC, Humphrey MB. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. Plos One. 2: e586. PMID 17611621 DOI: 10.1371/Journal.Pone.0000586  0.317
2006 Yao W, Balooch G, Balooch M, Jiang Y, Nalla RK, Kinney J, Wronski TJ, Lane NE. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization. Bone. 39: 460-9. PMID 16713415 DOI: 10.1016/J.Bone.2006.03.008  0.328
2006 Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, Kinney JH, Bonewald LF. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 21: 466-76. PMID 16491295 DOI: 10.1359/Jbmr.051103  0.329
2005 Yao W, Hadi T, Jiang Y, Lotz J, Wronski TJ, Lane NE. Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats Osteoporosis International. 16: 1939-1947. PMID 16086094 DOI: 10.1007/S00198-005-1969-2  0.332
2005 Offley SC, Guo TZ, Wei T, Clark JD, Vogel H, Lindsey DP, Jacobs CR, Yao W, Lane NE, Kingery WS. Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity Journal of Bone and Mineral Research. 20: 257-267. PMID 15647820 DOI: 10.1359/Jbmr.041108  0.306
2003 Lane NE, Yao W, Kinney JH, Modin G, Balooch M, Wronski TJ. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 2105-15. PMID 14672345 DOI: 10.1359/Jbmr.2003.18.12.2105  0.33
2003 Lane NE, Kumer J, Yao W, Breunig T, Wronski T, Modin G, Kinney JH. Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 14: 374-82. PMID 12768279 DOI: 10.1007/S00198-003-1374-7  0.32
2003 Ma YL, Bryant HU, Zeng Q, Schmidt A, Hoover J, Cole HW, Yao W, Jee WS, Sato M. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats. Endocrinology. 144: 2008-15. PMID 12697709 DOI: 10.1210/En.2002-221061  0.339
2003 Li CY, Jee WSS, Chen JL, Mo A, Setterberg RB, Su M, Tian XY, Ling YF, Yao W. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat. Calcified Tissue International. 72: 42-49. PMID 12370795 DOI: 10.1007/S00223-001-1086-Y  0.335
2003 Mo A, Yao W, Li C, Tian X, Su M, Ling Y, Zhang Q, Setterberg RB, Jee WS. Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats. Bone. 31: 402-6. PMID 12231413 DOI: 10.1016/S8756-3282(02)00835-9  0.316
2001 Soper DL, Milbank JB, Mieling GE, Dirr MJ, Kende AS, Cooper R, Jee WS, Yao W, Chen JL, Bodman M, Lundy MW, De B, Stella ME, Ebetino FH, Wang Y, et al. Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis. Journal of Medicinal Chemistry. 44: 4157-69. PMID 11708917 DOI: 10.1021/Jm010264B  0.314
2001 Chen JL, Yao W, Frost HM, Li CY, Setterberg RB, Jee WS. Bipedal stance exercise enhances antiresorption effects of estrogen and counteracts its inhibitory effect on bone formation in sham and ovariectomized rats. Bone. 29: 126-33. PMID 11502473 DOI: 10.1016/S8756-3282(01)00496-3  0.32
2001 Zhou H, Ma YF, Yao W, Cui L, Setterberg R, Liang CT, Jee WS. Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats. Calcified Tissue International. 68: 179-84. PMID 11351502 DOI: 10.1007/S002230001207  0.324
2001 Cui L, Ma YF, Yao W, Zhou H, Setterberg RB, Liang TC, Jee WS. Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain. Journal of Bone and Mineral Metabolism. 19: 29-37. PMID 11156470 DOI: 10.1007/S007740170057  0.321
2000 Yao W, Jee WS, Chen J, Tam CS, Setterberg RB, Frost HM. Erect bipedal stance exercise partially prevents orchidectomy-induced bone loss in the lumbar vertebrae of rats. Bone. 27: 667-75. PMID 11062354 DOI: 10.1016/S8756-3282(00)00377-X  0.319
2000 Yao W, Jee WS, Chen J, Liu H, Tam CS, Cui L, Zhou H, Setterberg RB, Frost HM. Making rats rise to erect bipedal stance for feeding partially prevented orchidectomy-induced bone loss and added bone to intact rats. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 15: 1158-68. PMID 10841185 DOI: 10.1359/Jbmr.2000.15.6.1158  0.31
Show low-probability matches.